Week 2 Flashcards
t/f- JAK2 inhib can be used for HSCT patient
t/f- inhib of jak/stat causes increase chance of replase
T - blocks T cell proliferation …used for GVHD!!
False - does not
clinical pres of AML
INC MYELOBLASTS»_space; dec everything downstream
- low grade fever/infection (pt interview = flu!) – low mature WBC
- fatigue/palpitations roaring in ears - low RBC
- bruising and bleeding - low platelets
T/F - hyperviscocity of blood is feature of AML
TRUE… why they get visionchanges, dyspnea and roaring in ears
how do we diagnose AML?
bone marrow biopsy - see >20% blasts
and test for myeloidbladt markers (MPO+, auer bodies)
what test do we do to distinguish good vs bad prognosis in AML?
Good: t(15, 17); t(8,21), Inv16
Poor: chrom 5, 7, 8, complex
Intermediate: Normal karyotype
good or bad prognosis in AML:
- chr 5,7,8 complex
- t(15,17)
- normal karyoptyr
- inv 16
- t(8,21)
Good: t(15, 17); t(8,21), Inv16
Poor: chrom 5, 7, 8, complex
Intermediate: Normal karyotype
T/F - majority of AML patients have normal karyoptyr which had more favorable prognosis than translocations like t(15,17)
false - is most common, but trans actually have GOOD prognosis
- *principles of AML therapy
- give ____ as induction therapy , when?»_space;> follow up eith BM biopsy» then do ____ if CR and _____ if not CR
- when do we do transplant?
induce with a month of anthracycline araC (if active disease)
-then consolidate ALL! with high dose AraC
CR = residual leukemia burden just below the level of detection Cure = CR beyond 5 years
- if low risk»_space; consolidate and observe
- if high risk» consolidate and transplant (esp if relapse)
we use retinoic acid and arsenic for ____ leukemia
acute promyelocytic leukemia
T/F - relapse AML has dismal prognosis in young and old patients
true
dx? 62 year old F presents with fatigue, RBC is 8, WBC is 21K, smear shows abnormal promyelocytes with primary granules. Neutrophil count is low. BM biopsy shows esterase+, myeloperoxidase+, t(15,19) mutation
AML»_space; specifically acute promyelocytic leukemia
what is difference between allogenic and autologous HSCT?
allo = from someone else (1/2 match dad/mom/sib) , stranger or cord blood
auto = own stem cells
what are indications for BM transplant in AML patient?
- if patient relapses
- or if patient at high risk and doesn’t respond
- *do risk startification during first block of induction treatment»_space; still have cancer 2 weeks later?»_space; then consolidate with another hig hdose ArC then»_space; TRANSPLANT
what are indications for hematopoteic stem cell transplant (big 3) - are they mostly allo or auto
MYELOMA #1 - almost all auto
NHL #2 - mostly auto
AML #3 - mostly allo
others less common = ALL, Hodgkins, MDS, CML
what is first step for HSCT:
- preparative regimen
- stem cell collection
- insurance approval
- engraftment
-insurance approval! and establish indication obv
GVHD occurs ____(after stem cell infusion or after engraftment)
AFTER ENGRAFTMENT ! before that there are no T cells ! becuase stem cells haven’t grafted into BM and started differentiationg
describe GVHD… what are acute v. chronic signs?
APC is from ____(host or donor)
T cells are from ____(host or donor)
GVHD = when donor T cells attack patient tissue (recognize antigens»_space; IL-12»_space; Th1»_space; IFN-gam + IL2»_space; NK and and CTL »_space; KILLL!
Acute = liver damage (big belly), skin (rash, no hair) and GI Chronic = arbritary > 100 days post engraftment = SKIN (rash, necrosis), oral ulcers, DRY EYES and DRY MOUTH, TIGHT skin/muscles/joints
are following pre- or post-engraftment complications:
- neutropenic fevers and sepsis
- nausea vomitting, mucositis
- anorexia
T/F- liver toxicity is common pre-engraftment complication
- all PRE
- liver/kidney/lungs are NOT common
T/F - GVHD is number 1 cause of death in HSCT patients
FALSE. its #2 .. behind “primary disease” (~40-50%)
GVHD and infection are tied #2/#3 - around ~15%
JAK2 kinase inhibitors block ____ cell activation in GVHD patient
T-cell
how do we “prepare” patient prior to HSCT (chemo, radiation, immunotherapy?)
-chemo +/- whole body radiation
HSCT permits ____(chemotherapy, immunotherapy) in allogenicc patient and ______ therapy in autogenic patient
chemotherapy in auto +/- immuno (TNF-alpha inhib) in allo
ENGRAFTMENT??
- need ___ and ____ adhesion molecules
- how do we “measure”
- homing of stem cells into bone marrow (occurs ~10 days post infusioN) … so for 1st ten days NO IMMUNE CELLS (need to tranfuse platelts, RBC, everything)
- VLA-4 and CD34
MEAURE - via chromosomes and variable # tandem repeats (VNTR) … basically a PCR band to make sure donor = host
are each part of innate or adaptive
- granulocytes
- NK
- T cells
- dendritic
T/F - innate immune system shaped by pathogen exposure
all innate except T
-innate NOT shaped by pathogen exposure,l only adaptive
–describe path from naiive B to plasma cell (follicular, mantle, naive, plasma cell)
–and where (blood, germinal center, mantle zone, marginal zone, bone marrow)
in blood: naive»_space;
in Mantel zone: mantle»_space;
in germinal center: follicular B-blast»_space; CENTROBLAST (BIG)
in marginal zone: monocytoid or centrocyte»_space; PLASMA (BM)
N>M>F>C> P
CD20 is target for _______ heme cancers
B-cells! esp the lymphomas
dx? 70 F presents with recurrent infection and fatigue, RBC low, cervical lymphadenopathy, elevated WBC, platelets normal, smear shows spherocytes and smudge cells, biopsy shows diffuse uniform pattern
- AML
- CML
- ALL
- CLL
- hodgkin lymphoma
- non-hodgkin lymphoma
CLL = SMEAR!
T/F - CLL median age of diagnosis is 40-50
T/F - more common in african americans
false - 72 median
false - cauc > AA
antibody production is ____(+/-/0) in CLL and risk of infection is ____(+/-/0)
- increased
- increased (becuase antibodies ARENT GOOD!)
- CBC and smear findings in CLL
- diagnosis of CLL requires >5000/ncl CLL lymphocytes in _______(periphery, marrow, LN) that are ______(polyclonal or monoclonal)
- increased WBC, smudge cells on blood smear
- CIRCULATING! cells with CLL MONOCLONAL IMMUNOPHENOTYPE (kappa/lambda ratio NOT 3:1)
- rouleux on periph smear indicates _____
- smudge cell on periph smear indicates _____
- myeloma
- CLL
dx? 58 yeara old onset of severe lumbar pain, tender to palp, has been tried lately, WBC low, hemoglobin low, platelet borderline low, Calcium high, globulin high, serum protein electrophoresis shows IgGk paraprotein spike 4.8
plasma cell MYELOMA»_space; back pain cuase eating away at bone, would expect lytic lesions on x-ray
where do you find the plasma cells in myeloma (periphery, lymph nodes, marrow)
MARROW!!! see lots of plasma cells, may see in periphery too
- -how does MM present
- -how is it diagnosed (3 things)
- fatigue (low RBC), bone pain, renal dysfunction (50%), hypercalcemia (25%), recurrent infections (low WBC)
- presence of M-protein in serum (>3gm, 97% of patients) presence of clonal bone marrow plasma cells, presence of tissue organ damage (inc Ca2+ , renal insufficiency, anemia, lytic bone lesions = CRAB)
difference between MM and smoldering
both = M protein and clonal bone marrow plasma cells
smoldering = NO CRAB (Ca2+ , renal, anemia, bone pain/lesions) ie, asymptomatic
what is MGUS? precursor of ______
- monoclona lgammopathy of undetermined significance = increased serum protein with M-spike on SPEP w/out organ damage found in MM
- -MYELOMA
what are values of following for MM, smoldering M, MGUS:
- marrow plasma cells (> or 3 or ,3)
- organ damage (CRAB, absent/present)
MM = >10%, >3, CRAB yes
SM = >10, >3, CRAB NO
MGUS =
T/F - B-cell lymphocytosis at increased risk of CLL and MGUS patients at increased risk of myeloma
FALSE
- B cell»_space; CLL (1%)
- MGUS»_space; myeloma
primary AL amyloidsis is associatd with _____ cancer
multiple myeloma … cranking out free light chains that are depositing in the tissues
difference between non-hodgkin and hodgkin
- -malignant cells
- -present (age, painful or painless lymphadenopathy where?)
- -B- symptoms??
- -importance of staging
NON - malig lymphoid cells (usually B - small or large) , painless lymphadenopathy in late adulthood , limited importance
HODGE = REED-STERNBERG, painless lymph “” in YOUNG ADULTS (B symptoms = weight loss,fever, night sweats), STAGING IMPORTANT
T/F - extranodal involvement is RARE in BOTH hodgkin and non-hodgkin
FALSE - rarely extranodal in HODGKINS (except HIV), often extranodal / diffuse in non-hodgkins